1. Home
  2. BHVN vs CSWC Comparison

BHVN vs CSWC Comparison

Compare BHVN & CSWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • CSWC
  • Stock Information
  • Founded
  • BHVN 2013
  • CSWC 1961
  • Country
  • BHVN United States
  • CSWC United States
  • Employees
  • BHVN N/A
  • CSWC N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • CSWC Textiles
  • Sector
  • BHVN Health Care
  • CSWC Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • CSWC Nasdaq
  • Market Cap
  • BHVN 1.5B
  • CSWC 1.3B
  • IPO Year
  • BHVN 2017
  • CSWC N/A
  • Fundamental
  • Price
  • BHVN $15.66
  • CSWC $22.54
  • Analyst Decision
  • BHVN Strong Buy
  • CSWC Buy
  • Analyst Count
  • BHVN 14
  • CSWC 4
  • Target Price
  • BHVN $54.62
  • CSWC $24.13
  • AVG Volume (30 Days)
  • BHVN 2.3M
  • CSWC 640.9K
  • Earning Date
  • BHVN 08-11-2025
  • CSWC 08-06-2025
  • Dividend Yield
  • BHVN N/A
  • CSWC 11.32%
  • EPS Growth
  • BHVN N/A
  • CSWC N/A
  • EPS
  • BHVN N/A
  • CSWC 1.64
  • Revenue
  • BHVN N/A
  • CSWC $209,032,000.00
  • Revenue This Year
  • BHVN N/A
  • CSWC $12.58
  • Revenue Next Year
  • BHVN $1,007.82
  • CSWC $12.67
  • P/E Ratio
  • BHVN N/A
  • CSWC $13.75
  • Revenue Growth
  • BHVN N/A
  • CSWC 10.52
  • 52 Week Low
  • BHVN $12.79
  • CSWC $17.46
  • 52 Week High
  • BHVN $55.70
  • CSWC $25.90
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 56.24
  • CSWC 48.04
  • Support Level
  • BHVN $14.23
  • CSWC $22.25
  • Resistance Level
  • BHVN $16.14
  • CSWC $22.77
  • Average True Range (ATR)
  • BHVN 0.86
  • CSWC 0.36
  • MACD
  • BHVN 0.10
  • CSWC -0.06
  • Stochastic Oscillator
  • BHVN 85.48
  • CSWC 52.25

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

Share on Social Networks: